Stocks and Investing Stocks and Investing
Thu, March 2, 2023
[ 12:00 AM ] - WOPRAI
Brent Bracelin Reiterated (AVDX) at Buy and Held Target at $11 on, Mar 2nd, 2023
[ 12:00 AM ] - WOPRAI
Timothy Chiodo Maintained (AVDX) at Buy and Held Target at $11 on, Mar 2nd, 2023
[ 12:00 AM ] - WOPRAI
Srini Pajjuri Initiated (AVGO) at Hold on, Mar 2nd, 2023
[ 12:00 AM ] - WOPRAI
Tristan Richardson Initiated (ARRY) at Buy and Held Target at $26 on, Mar 2nd, 2023
[ 12:00 AM ] - WOPRAI
Christian Wetherbee Maintained (ARCB) at Strong B .. y with Increased Target to $116 on, Mar 2nd, 2023
[ 12:00 AM ] - WOPRAI
Arren Cyganovich Maintained (BCSF) at Hold with Decreased Target to $13 on, Mar 2nd, 2023
[ 12:00 AM ] - WOPRAI
Mark Strouse Maintained (AY) at Hold with Decreased Target to $28 on, Mar 2nd, 2023
[ 12:00 AM ] - WOPRAI
Paul Chung Downgraded (AXON) to Hold and Held Target at $224 on, Mar 2nd, 2023
[ 12:00 AM ] - WOPRAI
Tim Long Maintained (AXON) at Buy with Increased Target to $222 on, Mar 2nd, 2023
Wed, March 1, 2023
[ 12:00 AM ] - WOPRAI
Bobby Griffin Maintained (AZO) at Buy on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (AZO) at Strong Buy on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (AZO) at Buy on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Michael Baker Maintained (AZO) at Hold on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Scot Ciccarelli Maintained (AZO) at Strong Buy on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Joshua Reilly Reiterated (AXON) at Strong Buy and Held Target at $240 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Sami Badri Maintained (AXON) at Buy with Increased Target to $237 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
William Power Maintained (AXON) at Buy with Increased Target to $237 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Graig Suvannavejh Maintained (AXSM) at Strong Buy with Decreased Target to $84 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Ami Fadia Maintained (BCYC) at Strong Buy with Decreased Target to $67 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Swayampakula Ramakanth Reiterated (BCYC) at Strong Buy and Held Target at $57 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Yanan Zhu Maintained (BEAM) at Buy with Decreased Target to $105 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Tyler Batory Maintained (BHR) at Buy with Decreased Target to $7 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Julian Mitchell Maintained (APG) at Buy with Increased Target to $25 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Andrew Kaplowitz Maintained (APG) at Strong Buy with Increased Target to $28 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Ashish Sabadra Maintained (APG) at Hold with Increased Target to $25 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Serge Belanger Reiterated (ARQT) at Strong Buy and Held Target at $46 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Vikram Purohit Maintained (ARQT) at Buy with Decreased Target to $50 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Jon Tower Maintained (CBRL) at Strong Sell with Increased Target to $92 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Andrew Wolf Maintained (CBRL) at Strong Buy with Increased Target to $130 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Vamil Divan Initiated (CALT) at Hold and Held Target at $18 on, Mar 1st, 2023

Vamil Divan Initiated (CALT) at Hold and Held Target at $18 on, Mar 1st, 2023


Published on 2024-10-28 02:02:29 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Guggenheim, Initiated "Calliditas Therapeutics AB (publ)" (CALT) at Hold and Held Target at $18 on, Mar 1st, 2023.

Vamil has made no other calls on CALT in the last 4 months.



There is 1 other peer that has a rating on CALT. Out of the 1 peers that are also analyzing CALT, 0 agree with Vamil's Rating of Hold.



This is the rating of the analyst that currently disagrees with Vamil

  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $79 on, Friday, February 24th, 2023
Contributing Sources